Assistant Professor, Radiation Oncology-Massachusetts General Hospital, Harvard Medical School
Radiation Oncology
Dr. Theodore S. Hong, MD
|
|
Give Review
Theodore S. Hong practices Radiation Oncology. He graduated from University of Connecticut School of Medicine. University of Connecticut School of Medicine is ranked 60/49 in Research/PrimaryCare. Theodore S. Hong, MD is a published doctor. He published 84 publications, including: 'Irradiation of FDG-PET-Defined Active BoneMarrow Subregions and Acute HematologicToxicity in Anal Cancer Patients Undergoing Chemoradiation.' Theodore S. Hong, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Association Between Very Small Tumor Size and Increased Cancer-Specific Mortality in Node-Positive Colon Cancer.
- Predictors of Lymph Node Metastasis in Western Early Gastric Cancer.
- Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Approp...
- Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response A...
- CT-guided implantation of intrahepatic fiducial markers for proton beam therapy of liver lesions: assessment of success rate and complications.
- Towards an integrated understanding of epidermal growth factor receptor biology for radiation therapy: integrins enter.
- Adapting a Drug Screening Platform to Discover Associations of Molecular Targeted Radiosensitizers with Genomic Biomarkers.
- Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
- Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
- Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer.
- Pancreatic adenocarcinoma.
- Radiation Therapy for Liver Tumors: Ready for Inclusion in Guidelines?
- Exploiting tumor shrinkage through temporal optimization of radiotherapy.
- Adjuvant Therapy for Gastric Cancers: More Answers or More Questions?
- A Phase 1/2 and Biomarker Study of Preoperative Short Course Chemoradiation With Proton Beam Therapy and Capecitabine Followed By Early Surgery for Resectable Pancreat...
- Intraductal Papillary Mucinous Neoplasm: Clinical Surveillance and Management Decisions.
- Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection.
- Constraints on Cosmic Strings from the LIGO-Virgo Gravitational-Wave Detectors.
- An Emerging Role for Radiation Therapy in the Treatment of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
- Genetic Mechanisms in Interval Colon Cancers.
- Mutational analysis and clinical correlation of metastatic colorectal cancer.
- The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation.
- Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.
- Treatment of Stage II-III Rectal Cancer Patients.
- Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer.
- Mutational and Clinical Predictors of Pathologic Complete Response in the Treatment of Locally Advanced Rectal Cancer.
- Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Mas...
- Chemoradiation therapy: localized esophageal, gastric, and pancreatic cancer.
- Noncurative Gastrectomy for Gastric Adenocarcinoma Should only be Performed in Highly Selected Patients.
- Radiotherapy for hepatocellular carcinoma with tumor vascular thrombus: ready for prime time?
- Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients.
- Targeted therapies with chemoradiation in esophageal cancer: development and future directions.
- Mitomycin in anal cancer: still the standard of care.
- Multidisciplinary management of early-stage rectal cancer.
- Impact of age and comorbidities on the treatment of gastrointestinal malignancies.
- Pancreatic Ductal Adenocarcinoma: Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a "True" R0 Resection?
- Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis.
- Heterogeneity in head and neck IMRT target design and clinical practice.
- Dose-Volume Effects on Patient-Reported Acute Gastrointestinal Symptoms During Chemoradiation Therapy for Rectal Cancer.
- Cancers of the colon and rectum: identical or fraternal twins?
- A Four-Dimensional Computed Tomography Analysis of Multiorgan Abdominal Motion.
- Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.
- Charged-particle therapy for hepatocellular carcinoma.
- T3N0 Rectal Cancer: Radiation for All?
- Case records of the Massachusetts General Hospital. Case 13-2011. A 49-year-old man with adenocarcinoma of the rectum.
- Tolerability of Combined Modality Therapy for Rectal Cancer in Elderly Patients Aged 75 Years and Older.
- Improved Planning Time and Plan Quality Through Multicriteria Optimization for Intensity-Modulated Radiotherapy.
- Proton radiotherapy: the biological effect of treating alternating subsets of fields for different treatment fractions.
- Short-course versus standard chemoradiation in t3 rectal cancer.
- Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head.
- Phase I Trial of Pelvic Nodal Dose Escalation with Hypofractionated IMRT for High-Risk Prostate Cancer.
- Dose-painted Intensity-modulated Radiation Therapy for Anal Cancer: A Multi-institutional Report of Acute Toxicity and Response to Therapy.
- Adoption of Preoperative Radiation Therapy for Rectal Cancer From 2000 to 2006: A Surveillance, Epidemiology, and End Results Patterns-of-Care Study.
- The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery.
- Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning.
- Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.
- Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer.
- Current management of gallbladder carcinoma.
- Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
- Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.
- Case records of the Massachusetts General Hospital. Case 19-2009. A 63-year-old woman with carcinoma of the gastroesophageal junction.
- Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer.
- Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning.
- Multicriteria optimization in intensity-modulated radiation therapy treatment planning for locally advanced cancer of the pancreatic head.
- External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.
- Rectal cancer at the crossroads: the dilemma of clinically staged T3, N0, M0 disease.
- Megavoltage computed tomography: an emerging tool for image-guided radiotherapy.
- Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment.
- Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard.
- Considerations in treatment planning for esophageal cancer.
- Impact of conventional radiotherapy on health-related quality of life and critical functions of the head and neck.
- Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
- Parotid area lymph node metastases from cutaneous squamous cell carcinoma: implications for diagnosis, treatment, and prognosis.
- Intensity-modulated radiation therapy in the management of head and neck cancer.
- The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.
- Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study.
- Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy.
- A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.
- Comparative Analysis of Radiosensitizers for K-RAS Mutant Rectal Cancers.
- Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control.
- Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.
- Advances in the Management of Gastric and Gastroesophageal Cancers.
Schools
University Of Connecticut School Of Medicine
University Wisconsin Hospital Wi
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
University of Wisconsin -
University of Connecticut School of Medicine
Hospital
-
Emerson Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1457342917 | |
| NPPES Provider LastName | HONG | |
| NPPES Provider FirstName | THEODORE | |
| NPPES Provider ZIPCode | 021142617 | |
| NPPES Provider State | MA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 28.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457342917 |
| Last Name Of The Provider | HONG |
| First Name Of The Provider | THEODORE |
| View All |
Similar Doctors
|
|
Dr. Joanna Y. Chin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John G. Phillips, MD |
|
|
Dr. Michael A. Dyer, MD |
|
|
Dr. Jennifer L. Pretz, MD |
|
|
Dr. Timur Mitin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea Ng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth H. Baldini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter Mauch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott R. Floyd, MD
This Doctor is OpenDoctor Recommended.
|